Treatment-related adverse events associated with HER2-Targeted antibody-drug conjugates in clinical trials: a systematic review and meta-analysis

BACKGROUND: Given the increasing use of HER2-targeted antibody–drug conjugates (ADCs) worldwide, the summary of toxicity incidence and profiles of these drugs is crucial to provide reference for clinical application. This meta-analysis aimed to estimate the mean incidences of treatment-related adver...

Descripción completa

Detalles Bibliográficos
Autores principales: Fu, Zhiwen, Liu, Jinmei, Li, Shijun, Shi, Chen, Zhang, Yu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9874347/
https://www.ncbi.nlm.nih.gov/pubmed/36712893
http://dx.doi.org/10.1016/j.eclinm.2022.101795

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9874347/
https://www.ncbi.nlm.nih.gov/pubmed/36712893
http://dx.doi.org/10.1016/j.eclinm.2022.101795

Ejemplares similares